Haematology 2018

Cumulative Incidence by Rituximab exposure

15.0

CI% at 5-yr (95CI) 10-yr (95CI)

HR (95CI)

p

7.2 (5.8-9.0) 5.0 (4.2-6.1) 2.7 (1.8-4.0)

9.0 (7.3-11.1) 5.9 (4.7-7.5) 3.8 (2.5-5.9)

1.00

12.5

0.67 (0.50-0.88) 0.38 (0.25-0.58)

0.004

<0.001

10.0

I-M-

7.5

I+ M-

5.0

Cumulative risk x100

I+M+

2.5

0.0

0

1

2

3

4

5

6

7

8

9 10

Follow-up, years